Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2024-01-24 Transaction in Own Shar…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'Transaction in Own Shares' and details the purchase of 145,000 ordinary shares as part of a share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming the information is provided by RNS (the news service of the London Stock Exchange) confirms it is a formal regulatory disclosure, but the specific content dictates the POS classification over the general RNS fallback.
2024-01-24 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'Transaction in Own Shares' and details the purchase of 200,000 ordinary shares as part of a 'share buyback programme'. This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance). The presence of an RNS Number and the closing statement referencing RNS as the news service of the London Stock Exchange confirms it is a regulatory announcement, but the specific content points overwhelmingly to the POS category. The document length (3235 chars) is not short enough to trigger the RPA/RNS rule based on the 'announcement of a report' criteria, as this is a substantive transaction disclosure.
2024-01-23 English
Autolus announces acceptance of BLA for obe-cel
Regulatory Filings Classification · 100% confidence The document is identified by the header 'RNS Number : 4684A' and contains boilerplate language referencing 'RNS, the news service of the London Stock Exchange' and compliance with the Financial Conduct Authority. The content is a press release from Syncona Limited noting an announcement by its portfolio company, Autolus Therapeutics, regarding the FDA's acceptance of a Biologics License Application (BLA) for a drug candidate. This type of material—a general, time-sensitive corporate announcement distributed via an official news service (RNS) that doesn't fit neatly into specific financial reporting categories like 10-K, ER, or IR—is best classified as a general Regulatory Filing or Regulatory News Service announcement. Since the document is a direct announcement of a significant event (FDA acceptance) distributed through the RNS system, and it is not a specific report like an Earnings Release (ER) or Interim Report (IR), the most appropriate classification is RNS (Regulatory Filings/Miscellaneous Regulatory Announcement).
2024-01-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'Transaction in Own Shares' as its subject. It details the purchase of ordinary shares by the company as part of a previously announced 'share buyback programme'. The content focuses entirely on the number of shares purchased, the price paid, and the resulting change in total voting rights. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of 'RNS Number' and the closing statement about RNS confirms it is a regulatory announcement, but the specific subject matter dictates the more precise classification.
2024-01-22 English
Freeline announces further data
M&A Activity Classification · 99% confidence The document begins with 'RNS Number' and is dated '19 January 2024'. It contains an announcement from Syncona Limited regarding an update from its portfolio company, Freeline Therapeutics, concerning clinical trial data (Phase I/II GALILEO-1 trial for Gaucher disease). The text concludes with standard disclaimers and information about RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. This format—a brief announcement of material, non-financial or preliminary data, disseminated via the RNS system—is characteristic of a general regulatory announcement that doesn't fit the specific categories like Earnings Release (ER), Interim Report (IR), or Director's Dealing (DIRS). Therefore, the most appropriate classification is the general regulatory filing category.
2024-01-19 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'Transaction in Own Shares' where the company purchased 200,000 of its ordinary shares as part of a previously announced 'share buyback programme'. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type code is POS (Transaction in Own Shares). The presence of the RNS Number and the closing statement confirming RNS as the information provider suggests it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-01-18 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.